Finance

Lists
Why is TECN down २.१३%?
Dive Deeper
TECN:SWX
Tecan Group AG
CHF २३८.६०
-२.१३%
(-५.२०) 1D
नोभेम्बर २०, १७:३०:२३ GMT+१  ·   CHF
All symbols
SymbolPriceChange% Change
Generating top insights for TECN...
Open
CHF २४१.००
High
CHF २४१.८०
Low
CHF २३५.२०
Mkt. cap
३.०६ अरब
Avg. vol.
६७.०८ हजार
Volume
५६.५७ हजार
Dividend
१.२६%
Quarterly dividend
CHF ०.७५
Ex-dividend date
२०२६ अप्रिल १७
52-wk high
CHF २७८.००
52-wk low
CHF ११०.६०
EPS
-CHF ९.२०
Shares outstanding
१.२८ करोड
No. of employees
३ हजार
Open
CHF २४१.००
High
CHF २४१.८०
Low
CHF २३५.२०
Mkt. cap
३.०६ अरब
Avg. vol.
६७.०८ हजार
Volume
५६.५७ हजार
Dividend
१.२६%
Quarterly dividend
CHF ०.७५
Ex-dividend date
२०२६ अप्रिल १७
52-wk high
CHF २७८.००
52-wk low
CHF ११०.६०
EPS
-CHF ९.२०
Shares outstanding
१.२८ करोड
No. of employees
३ हजार
News stories
From web sources and news partners
Profile
Tecan Group Ltd. is a Swiss company providing laboratory instruments and solutions in biopharmaceuticals, forensics, clinical diagnostics and medical technology for pharmaceutical and biotechnology companies, university research departments, diagnostic laboratories and clinics. The company specializes in laboratory automation. As an original equipment manufacturer, it develops and manufactures OEM instruments, components and medical devices that are then distributed by partner companies. Founded in Switzerland, in 1980, the company has over 3,500 employees, owns production and research and development sites in North America, Europe and APAC and maintains a sales and service network in 52 countries. In 2021, Tecan generated sales of CHF 946 million. Registered shares of Tecan Group are traded on the SIX Swiss Exchange. Wikipedia
About Tecan Group AG
CEO-
Employees३ हजार
Founded१९८०
HeadquartersMännedorf, Zurich, स्विट्जरल्यान्ड
SectorHealth Care
Industry-
Websitetecan.com
Previous reportsAll values in CHF
Loading Previous Earnings...
Revenue
Net income
All values in CHF
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
२२.१५ करोड
२२.१५ करोड
२१.३८ करोड
२१.३८ करोड
Cost of goods sold
१४.५७ करोड
१४.५७ करोड
१४.१३ करोड
१४.१३ करोड
Cost of revenue
१४.५७ करोड
१४.५७ करोड
१४.१३ करोड
१४.१३ करोड
Research and development expenses
१.५८ करोड
१.५८ करोड
१.६१ करोड
१.६१ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
४.८४ करोड
४.८४ करोड
४.७१ करोड
४.७१ करोड
Operating expense
६.४९ करोड
६.४९ करोड
६.२१ करोड
६.२१ करोड
Total operating expenses
२१.०६ करोड
२१.०६ करोड
२०.३४ करोड
२०.३४ करोड
Operating income
१.०९ करोड
१.०९ करोड
१.०३ करोड
१.०३ करोड
Other non operating income
-२.२६ लाख
-२.२६ लाख
-
-
EBT including unusual items
-६.२२ करोड
-६.२२ करोड
७८.७२ लाख
७८.७२ लाख
EBT excluding unusual items
९४.७० लाख
९४.७० लाख
९३.२३ लाख
९३.२३ लाख
Income tax expense
२०.९६ लाख
२०.९६ लाख
१७.३६ लाख
१७.३६ लाख
Effective tax rate
-३.३७%
-३.३७%
२२.०५%
२२.०५%
Other operating expenses
६.५० लाख
६.५० लाख
-११.२४ लाख
-११.२४ लाख
Net income
-६.४३ करोड
-६.४३ करोड
६१.३६ लाख
६१.३६ लाख
Net profit margin
-२९.०२%
-२९.०२%
२.८७%
२.८७%
Earnings per share
-
-
-
-
Interest and investment income
६.१६ लाख
६.१६ लाख
५.९० लाख
५.९० लाख
Interest expense
-६.६४ लाख
-६.६४ लाख
-६.४८ लाख
-६.४८ लाख
Net interest expenses
-४८.०० हजार
-४८.०० हजार
-५८.५० हजार
-५८.५० हजार
Depreciation and amortization charges
-
-
-
-
EBITDA
१.६३ करोड
१.६३ करोड
२.१७ करोड
२.१७ करोड
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू